
Kodiak Sciences is a biopharmaceutical company dedicated to developing transformative therapeutics for high prevalence retinal diseases. Utilizing its innovative ABC Platform™, which merges antibody-based and chemistry-based therapies, Kodiak focuses on creating next-generation medicines like tarcocimab, KSI-501, and KSI-101 to address unmet needs in retinal vascular and inflammatory diseases. The company fosters a culture of curiosity, creativity, compassion, and courage, aiming to make a significant impact in the field of ophthalmic therapeutics.
Kodiak Sciences is seeking a highly motivated Organic Chemist to join their Discovery Medicine group. This role involves designing novel ophthalmic medicines and delivery platforms, leveraging antibody biopolymer conjugate (ABC) technology and a multidisciplinary team. The position focuses on researching, developing, and commercializing treatments for various ophthalmology diseases.
Kodiak Sciences is a biopharmaceutical company dedicated to developing transformative therapeutics for high prevalence retinal diseases. Utilizing its innovative ABC Platform™, which merges antibody-based and chemistry-based therapies, Kodiak focuses on creating next-generation medicines like tarcocimab, KSI-501, and KSI-101 to address unmet needs in retinal vascular and inflammatory diseases. The company fosters a culture of curiosity, creativity, compassion, and courage, aiming to make a significant impact in the field of ophthalmic therapeutics.